Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.

Patel R, Fleming J, Mui E, Loveridge C, Repiscak P, Blomme A, Harle V, Salji M, Ahmad I, Teo K, Hamdy FC, Hedley A, van den Broek N, Mackay G, Edwards J, Sansom OJ, Leung HY.

EMBO Mol Med. 2018 Apr;10(4). pii: e8347. doi: 10.15252/emmm.201708347.

2.

Metformin selectively targets redox control of complex I energy transduction.

Cameron AR, Logie L, Patel K, Erhardt S, Bacon S, Middleton P, Harthill J, Forteath C, Coats JT, Kerr C, Curry H, Stewart D, Sakamoto K, Repiščák P, Paterson MJ, Hassinen I, McDougall G, Rena G.

Redox Biol. 2018 Apr;14:187-197. doi: 10.1016/j.redox.2017.08.018. Epub 2017 Aug 26.

3.

General Force-Field Parametrization Scheme for Molecular Dynamics Simulations of Conjugated Materials in Solution.

Wildman J, Repiščák P, Paterson MJ, Galbraith I.

J Chem Theory Comput. 2016 Aug 9;12(8):3813-24. doi: 10.1021/acs.jctc.5b01195. Epub 2016 Jul 21.

4.

Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.

Ahmad I, Mui E, Galbraith L, Patel R, Tan EH, Salji M, Rust AG, Repiscak P, Hedley A, Markert E, Loveridge C, van der Weyden L, Edwards J, Sansom OJ, Adams DJ, Leung HY.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8290-5. doi: 10.1073/pnas.1601571113. Epub 2016 Jun 29.

5.

Biomolecular mode of action of metformin in relation to its copper binding properties.

Repiščák P, Erhardt S, Rena G, Paterson MJ.

Biochemistry. 2014 Feb 4;53(4):787-95. doi: 10.1021/bi401444n. Epub 2014 Jan 24.

PMID:
24433134

Supplemental Content

Loading ...
Support Center